Ling Peng Kui Xiao Jian Cui Xiang-Hua Ye Yong-Chang Zhang Li Mao Giovanni Selvaggi Jennifer Yen Justin Stebbing
10.2147/OTT.S310756
Onco Targets Ther
2021 May 25;14:3409-3415.
alk nsclc alectinib ensartinib hyperbilirubinemia
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/34079286/
Case Reports
PMC8164872
34079286
Successful Treatment with Ensartinib After Alectinib-induced Hyperbilirubinemia in ALK-Positive NSCLC
2021